Peter Scully
- Ophthalmology top 1%
- Ocular Oncology and Treatments 5
- Oncology top 2%
- Cancer-related Molecular Pathways 5
- Viral-associated cancers and disorders 1
- Cancer Research top 10%
- Molecular Biology top 10%
- Retinoids in leukemia and cellular processes 1
- Genetics top 5%
- Virus-based gene therapy research 2
-
- interferon and immune responses 2
-
- Nanoplatforms for cancer theranostics 1
- Laser-Ablation Synthesis of Nanoparticles 1
- Co-authors
- Wen‐Hwa LeeJin‐Yuh ShewPhang‐Lang ChenRobert BooksteinJean Y. J. WangJin-Yuh ShewEva Y.-H.P. LeeMartin Haas
- Cited by
- OphthalmologyOncologyCancer Research
- Partner nations
- United StatesBelarus
In The Last Decade
Peter Scully
8 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Ophthalmology 587
- Oncology 1.4k
- Cancer Research 266
- Molecular Biology 1.1k
- Genetics 443
Countries citing papers authored by Peter Scully
This map shows the geographic impact of Peter Scully's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Scully with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Scully more than expected).
Fields of papers citing papers by Peter Scully
This network shows the impact of papers produced by Peter Scully. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Scully. The network helps show where Peter Scully may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Scully, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 2 | |
| 2 | Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Genebreakdown → | 1990 | 523 |
| 3 | 1990 | 7 | |
| 4 | 1990 | 61 | |
| 5 | Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiationbreakdown → | 1989 | 852 |
| 6 | Inactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancersbreakdown → | 1988 | 515 |
| 7 | AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens. | 1988 | 38 |
| 8 | 1982 | 21 |
About Peter Scully
Peter Scully is a scholar working on Ophthalmology, Otorhinolaryngology and Oncology, having authored 8 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Ocular Oncology and Treatments (5 papers), interferon and immune responses (2 papers), Virus-based gene therapy research (2 papers), Nanoplatforms for cancer theranostics (1 paper), Viral-associated cancers and disorders (1 paper), Laser-Ablation Synthesis of Nanoparticles (1 paper) and Retinoids in leukemia and cellular processes (1 paper). The work is most often cited by research in Ophthalmology (587 citations), Oncology (1.4k citations) and Cancer Research (266 citations). Peter Scully has collaborated with scholars based in United States and Belarus. Frequent co-authors include Wen‐Hwa Lee, Jin‐Yuh Shew, Phang‐Lang Chen, Robert Bookstein, Jean Y. J. Wang, Jin-Yuh Shew, Eva Y.-H.P. Lee, Martin Haas, Lee Wh and J Cheng. Their work appears in journals such as Science, Blood, Cell, The Laryngoscope and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.